Korean Air Lines Co. and Asiana Airlines Inc. will offer non-scheduled flights to India next month to bring home South Koreans residing there.
Asiana plans to provide four flights while Korean Air will offer one flight to the South Asian country, which has reported over 200,000 coronavirus deaths.
The non-scheduled flights by South Korea's two biggest carriers are subject to the approval of the Ministry of Land, Infrastructure, and Transport.
The two airlines may provide more non-scheduled flights to India depending on demands.
Korean Air suspended flights to India since March 2020 due to entry restrictions to stem the virus surge while Asiana stopped offering in July 2019 before the pandemic.
Passenger jets from India that are bound for Incheon, South Korea are required to occupy less than 60 percent of their seats, and the proportion of South Koreans needs to exceed 90 percent.


Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 



